Publications by authors named "Sankalp Arora"

Claim this Profile
C
Cytomolecular Mechanisms of Relapse and Post-Relapse Outcomes After Frontline FLT3 Inhibitor-Based Therapy in FLT3 -Mutated AML.
Sankalp Arora, Sanam Loghavi, Naval Daver, Farhad Ravandi, Courtney D DiNardo

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation.
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, Indraneel Deshmukh, Jayastu Senapati

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical interrogation of aberrations and its impact on survival in patients with myeloid neoplasms.
Jayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, Guillin Tang, Tapan Kadia, Sankalp Arora

Haematologica· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.
Naval Daver, Jayastu Senapati, Hagop M Kantarjian, Bofei Wang, Patrick K Reville, Sankalp Arora

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.
Johannes M Waldschmidt, Noori Sotudeh, Sankalp Arora, Tushara Vijaykumar, Praveen Anand

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational drugs in early phase trials for myelofibrosis.
Sankalp Arora, Pankit Vachhani, Prithviraj Bose

Expert Opin Investig Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry.
Mackenzie E Fowler, Kelly M Kenzik, Mustafa Al-Obaidi, Christian Harmon, Smith Giri, Sankalp Arora

J Geriatr Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, Udita Gupta, Vishruti Pandya

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges.
Sankalp Arora, Palash Asawa, Aravind Ramakrishnan, Carlos Bachier, Navneet S Majhail

Hematol Oncol Stem Cell Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.
Sankalp Arora, Mackenzie E Fowler, Christian Harmon, Mustafa Al-Obaidi, Darryl Outlaw

JCO Oncol Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
Omer Jamy, Sankalp Arora, Ruby Meredith, Donna Salzman, Antonio Di Stasi

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022.
Sankalp Arora, Palash Asawa, Nilansh Kataria, Lizza E L Hendriks, Aakash P Desai

Cancer Invest· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
Sankalp Arora, Carl Zainaldin, Srilakshmi Bathini, Udita Gupta, Sarah Worth

Leuk Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant.
Nishant R Tiwari, Sankalp Arora, Aditya G Tolat, Saad Paul Shaheen, Vivek R Sharma

Ann Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia.
Sankalp Arora, Pankit Vachhani, Kimo Bachiashvili, Omer Jamy

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant.
Anant Gokarn, Anup Toshniwal, Amogh Pathak, Sankalp Arora, Avinash Bonda

Biol Blood Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis